LINDSEY MYERS: Open Payments
NPI 1295517316 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 19 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| CSL Behring | 2 | $46 |
| Novo Nordisk Inc | 2 | $31 |
| Medtronic, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Tris Pharma Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: REXULTI, Andembry, MINIMED 780G, FANAPT, JOURNAVX, Dyanavel XR, ELIQUIS, VERQUVO.
Industry payments across IN — which companies pay providers there.
